Antimicrobial stewardship interventions: Thinking inside and outside the box

Infectious Disease Clinics of North America

Volumn 28, Issue 2, 2014, Pages 301-313

  Hamilton, Keith W ^a   Fishman, Neil O ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antimicrobial stewardship; End of life; Multidisciplinary rounds; Penicillin skin testing; Transitions in care; Ward rounds

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ABDOMINAL INFECTION; ALLERGY TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BEHAVIOR CHANGE; BONE INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; DRUG INDICATION; DRUG SURVEILLANCE PROGRAM; ELECTRONIC PRESCRIBING; ENDOCARDITIS; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HEALTH PROMOTION; HOSPITAL INFECTION; HUMAN; INFECTIOUS ARTHRITIS; MEDICAL AUDIT; MEDICATION ERROR; MULTIDRUG RESISTANCE; NONHUMAN; PALLIATIVE THERAPY; PATIENT ADVOCACY; PATIENT CARE; PENICILLIN ALLERGY; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; PROSTHESIS INFECTION; PUBLIC HEALTH; REVIEW; SKIN INFECTION; SKIN TEST; SOFT TISSUE INFECTION; STEVENS JOHNSON SYNDROME; SURGICAL INFECTION; TOXIC EPIDERMAL NECROLYSIS; DRUG HYPERSENSITIVITY; DRUG UTILIZATION; HOSPITAL; INAPPROPRIATE PRESCRIBING; PREVENTION AND CONTROL; STANDARDS;

ANTI-INFECTIVE AGENTS; CONTINUITY OF PATIENT CARE; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HOSPITALS; HUMANS; INAPPROPRIATE PRESCRIBING; PRACTICE GUIDELINES AS TOPIC;

EID: 84901234506     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2014.01.003     Document Type: Review

References (45)

1. Dellit T.H., Owens R.C., McGowan J.E., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.
2. Septimus E.J., Owens R.C. Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis 2011, 53:S8-S14.
3. Pope S.D., Dellit T.H., Owens R.C., et al. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009, 30:97-98.
4. Doron S., Davidson L.E. Antimicrobial stewardship. Mayo Clin Proc 2011, 86:1113-1123.
5. Carling P., Fung T., Killion A., et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003, 24:699-706.
6. Fraser G.L., Stogsdill P., Dickens J.D., et al. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997, 157:1689-1694.
7. Solomon D.H., Van Houten L., Glynn R.J., et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001, 161:1897-1902.
8. Tamma P.D., Cosgrove S.E. Antimicrobial stewardship. Infect Dis Clin North Am 2011, 25:245-260.
9. Cairns K.A., Jenney A.W., Krishnaswamy S., et al. Early experience with antimicrobial stewardship ward rounds at a tertiary referral hospital. Med J Aust 2012, 196:34-35.
10. DiazGranados C.A. Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes. Am J Infect Control 2012, 40:526-529.
11. Hecker M.T., Aron D.C., Patel N.P., et al. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003, 163:972-978.
12. Polk R.E., Hohmann S.F., Medvedev S., et al. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011, 53:1100-1110.
13. Juran J.M. Quality-control handbook 1951, McGraw-Hill, New York.
14. Braden C.R., Dowell S.F., Jernigan D.B., et al. Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome. Emerg Infect Dis 2013, 19:864-869.
15. Mathematica Policy Research, Harvard School of Public Health, Robert Wood Johnson Foundation Health Information Technology in the United States: Better Information Systems for Better Care, 2013 2013, 9. Robert Wood Johnson Foundation, Princeton (NJ). C.M. DesRoches, M.W. Painter, A.K. Jha (Eds.).
16. Schulz L., Osterby K., Fox B. The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record. Infect Control Hosp Epidemiol 2013, 34:1259-1265.
17. Hermsen E.D., VanSchooneveld T.C., Sayles H., et al. Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol 2012, 33:412-415.
18. Huang Y., Reichley R.M., Noirot L.A., et al. Automated dose checking and intervention for bariatric patients. AMIA Annu Symp Proc 2007, 983.
19. Resetar E., Reichley R.M., Noirot L.A., et al. Implementing daily dosing rules using a commercial rule base. AMIA Annu Symp Proc 2006, 1073.
20. Charneski L., Deshpande G., Smith S.W. Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy 2011, 8:742-747.
21. Unger N.R., Gauthier T.P., Cheung L.W. Penicillin skin testing: potential implications for antimicrobial stewardship. Pharmacotherapy 2013, 33:856-867.
22. Forrest D.M., Schellenberg R.R., Thien V.V., et al. Introduction of a practice guideline for penicillin skin testing improves the appropriateness of antibiotic therapy. Clin Infect Dis 2001, 12:1685-1690.
23. Arroliga M.E., Radojicic C., Gordon S.M., et al. Aprospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit. Infect Control Hosp Epidemiol 2003, 5:347-350.
24. del Real G.A., Rose M.E., Ramirez-Atamoros M.T., et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol 2007, 4:355-359.
25. Raja A.S., Lindsell C.J., Bernstein J.A., et al. The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 2009, 1:72-77.
26. Park M., Markus P., Matesic D., et al. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006, 5:681-687.
27. Boockvar K., Carlson LaCorte H., Giambanco V., et al. Medication reconciliation for reducing drug-discrepancy adverse events. Am J Geriatr Pharmacother 2006, 4:236-243.
28. Shehab N., Patel P.R., Srinivasan A., et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008, 47:735-743.
29. Chemaly R.F., Barbara de Parres J., Rehm S.J., et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis 2002, 34:1179-1183.
30. Chalasani N., Fontana R.J., Bonkovsky H.L., et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008, 135:1924-1934.
31. Tice A.D., Rehm S.J., Dalovisio J.R., et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004, 38:1651-1672.
32. Bond C.A., Raehl C.L. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy. Am J Health Syst Pharm 2005, 62:1596-1605.
33. Chary A., Tice A.D., Martinelli L.P., et al. Experience of infectious disease consultations with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis 2006, 43:1290-1295.
34. Shrestha N.K., Bhaskaran A., Scalera N.M., et al. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. JHosp Med 2012, 7:365-369.
35. Keller S.C., Ciuffetelli D., Bilker W., et al. The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy. JPharm Tech 2013, 29:205-214.
36. Shrestha N.K., Bhaskaran A., Scalera N.M., et al. Antimicrobial stewardship at transition of care from hospital to community. Infect Control Hosp Epidemiol 2012, 33:401-404.
37. White P., Kuhlenschmidt H., Vancura B., et al. Antimicrobial use in patients with advanced cancer receiving hospice care. JPain Symptom Manage 2003, 25:438-443.
38. Reinbolt R., Shenk A., White P., et al. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. JPain Symptom Manage 2005, 30:175-182.
39. Albrecht J.S., McGregor J.C., Fromme E.K., et al. Anationwide analysis of antibiotic use in hospice care in the final week of life. JPain Symptom Manage 2013, 46:483-490.
40. Vitetta L., Kenner D., Sali A. Bacterial infections in terminally ill hospice patients. JPain Symptom Manage 2000, 20:326-334.
41. Levin P.D., Simor A.E., Moses A.E., et al. End-of-life treatment and bacterial antibiotic resistance. Chest 2010, 138:588-594.
42. Cooke F.J., Holmes A.H. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 2007, 30:25-29.
43. Thakkar K., Gilchrist M., Dickinson E., et al. Aquality improvement programme to increase compliance with an anti-infective prescribing policy. JAntimicrob Chemother 2011, 66:1916-1920.
44. Rohde J.M., Jacobsen D., Rosenberg D.J. Role of the hospitalist in antimicrobial stewardship: a review of work completed and description of multisite collaborative. Clin Ther 2013, 35:751-757.
45. Vincent J.L., Rello J., Marshall J., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.